Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BIMINI Biotech logo — Curing cancer

BIMINI Biotech

Curing cancer

Founded 2019 The Netherlands The Netherlands 10 employees Seed Total: $3.20M Biotechnology, Health Care +1

General Information

Company Name BIMINI Biotech
Founded Year 2019
Location The Netherlands The Netherlands
Employees 10
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Business Model B2B, B2D
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with BIMINI Biotech. To contact BIMINI Biotech, visit biminibiotech.nl.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Grant Received Sep 11, 2026

BIMINI Biotech and Radboudumc have been awarded a Health Holland SME grant of €532.292 for the AUTO-WASP project.

Get alerts when BIMINI Biotech shows new signals

About BIMINI Biotech

BIMINI Biotech is a promising biotech startup founded in 2019, specializing in the development of unique compounds for oncology. This innovation-driven company is positioning itself in the cutting-edge field of cancer treatment, embarking on novel approaches that could redefine therapeutic strategies.

While their specific headquarters and detailed industry focus are not disclosed, BIMINI Biotech has successfully attracted attention from notable investors. On 01 January 2025, the company secured a €3.00M seed investment, supported by a prominent consortium including InnovationQuarter, Torrey Pines Investment, and Libertatis Ergo Holding B.V.

This surge of investment underscores the confidence in BIMINI Biotech's potential to bring about transformative advancements in oncology. With a strong foundation of investor backing, they present an attractive opportunity for further investments as they continue to innovate in the biotech landscape.

Taxonomy: oncology, growth hormone receptor, insulin-like growth factor 1, therapeutic strategies, metabolic diseases, anti-aging, innovative compounds, biotech startup, cancer treatment, drug development, hormone receptor targeting

Services & Products

Development of therapeutics for oncology
Pre-clinical testing of WASP modulators
Licensing of innovative drug compounds

Target Customers

Pharmaceutical companies Research institutions Healthcare providers specialized in cancer treatment

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed €3.00M 3
InnovationQuarter Torrey Pines Investment Libertatis Ergo Holding B.V.
InnovationQuarter, Torrey Pines Investment +1
01 Jan 2025
Seed €200.00K 1
UNIIQ - Finance for the Future
UNIIQ - Finance for the Future
01 Nov 2020
Spinout Undisclosed 1
USI Università della Svizzera italiana
01 Jan 2019

Latest News

View All
German startup T-CURX secures €17.7 million to support development of new cancer treatments — Eu-startups
German startup T-CURX secures €17.7 million to support development of new cancer treatments
Eu-startups Dec 17, 2025
As cancer cases surge toward 35 million by 2050, Finland’s Gosta Labs raises €7.5 million to ease on... — Eu-startups
As cancer cases surge toward 35 million by 2050, Finland’s Gosta Labs raises €7.5 million to ease oncology workloads
Eu-startups Nov 27, 2025
The UK’s Scripta Therapeutics raises over €10 million to “flip the script” on drug discovery — Eu-startups
The UK’s Scripta Therapeutics raises over €10 million to “flip the script” on drug discovery
Eu-startups Nov 13, 2025
HealthTech startup BIMINI Biotech secures €3 million to develop cancer treatments — Eu-startups
HealthTech startup BIMINI Biotech secures €3 million to develop cancer treatments
Eu-startups Jan 13, 2025

BIMINI Biotech Alternatives & Competitors

View All Alternatives
BIMINI Biotech vs
Cybrexa Therapeutics
Cybrexa Therapeutics United States

Changing the paradigm for cancer treatment through the development of antigen-independent peptide dr...

Series B
11 employees
Biotechnology, Health and Wellness
BIMINI Biotech vs
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. United States

Harnessing the power of p53 to treat cancer

Series D
70 employees
Biopharma, Biotechnology
BIMINI Biotech vs
TheraCryf
TheraCryf United Kingdom

TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative the...

Post-IPO Equity
9 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About BIMINI Biotech

Curing cancer
BIMINI Biotech was founded in 2019.
BIMINI Biotech is headquartered in The Netherlands.
BIMINI Biotech operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on oncology, growth hormone receptor, insulin-like growth factor 1 and therapeutic strategies. Its customers include Pharmaceutical companies, Research institutions and Healthcare providers specialized in cancer treatment.
BIMINI Biotech has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.
BIMINI Biotech has approximately 10 employees.
BIMINI Biotech has completed 3 funding rounds, raising a total of $3.20M. The latest funding stage is Seed.
BIMINI Biotech offers: Development of therapeutics for oncology, Pre-clinical testing of WASP modulators, Licensing of innovative drug compounds.
Top alternatives and competitors to BIMINI Biotech include Cybrexa Therapeutics, PMV Pharmaceuticals, Inc., TheraCryf, NBE-Therapeutics AG, Alterome Therapeutics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIMINI Biotech and Cybrexa Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BIMINI Biotech, https://bouncewatch.com/company/bimini-biotech-1, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes